At CytoVive™ we believe that all patients deserve access to next generation treatments, and our mission is to bring healthcare professionals that next generation of FDA compliant regenerative treatment options. We seek out and deal with only top tier vendors that specialize in the research and development of advanced regenerative medical treatments and medical devices. CytoVive™ maintains direct vertical integration with all of our vendors in order to save you money and ensure that you receive an unparallelled client service experience. All CytoVive™ products and devices go through an extensive vetting process for the following criteria: 1. Must have zero adverse events reported with use. 2. Must possess proprietary qualities that revolutionize their respective application(s). 3. Must be FDA cleared and compliant -      A) Registered and regulated under 21 CFR Part 1271 & PHS Act Section 361.      B) Registered and regulated as a 510(k) device under 21 CFR Part 807.92 (a) (3). 4. Allograft Products must be certified by an independent laboratory for sterility and viability.